Showing results (331-340 of 507) with videos related to

Sort By:
Pageof 51
The Journal of Clinical Investigation|April 29, 1998
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytesD M Koelle, C M Posavad, G R Barnum, et al.
American Journal of Clinical Pathology|February 1, 1992
Interference of recombinant soluble CD4 immunoglobulin G in flow cytometric measurement of CD4+ lymphocytesP G Kidd, G D Austin, A C Collier, et al.
Vaccine|February 10, 2009
Use of predictive markers of HIV disease progression in vaccine trialsS Gurunathan, R El Habib, L Baglyos, et al.
The Journal of Infectious Diseases|April 1, 1990
Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infectionG J Mertz, R Ashley, R L Burke, et al.
Pediatric Blood & Cancer|October 14, 2004
Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapyAndrew M Davidoff, Bethany L Corey, Fredric A Hoffer, et al.
The New England Journal of Medicine|March 23, 2000
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive personsA Wald, J Zeh, S Selke, et al.
AIDS (London, England)|April 19, 2000
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and SydneyP Vanhems, J Hughes, A C Collier, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrencesM J Levin, F N Judson, L Eron, et al.
JAMA|May 20, 1988
Oral acyclovir for treatment of first-episode herpes simplex virus proctitisA M Rompalo, G J Mertz, L G Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panelM A Sande, D Armstrong, L Corey, et al.
Pageof 51